Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival

Background: Multiple myeloma is a malignant haematological neoplasm characterised by clonal proliferation of plasma cells, with a complex clinical picture, and a significant impact on patient survival, in which the prognosis evaluation of patients is of great importance. Objectives: In this single-c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Melania Carlisi, Rosalia Lo Presti, Corinne Spoto, Salvatrice Mancuso, Sergio Siragusa, Gregorio Caimi
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-11-01
Series:	Therapeutic Advances in Hematology
Online Access:	https://doi.org/10.1177/20406207241298865
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma
by: Salvatrice Mancuso, et al.
Published: (2020-06-01)

Predicting survival of persons with newly-diagnosed multiple myeloma
by: Limei Zhang, et al.
Published: (2025-08-01)

CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
by: Vincenzo Accurso, et al.
Published: (2020-01-01)

Exciting New Data in Newly Diagnosed Multiple Myeloma
by: Kaveh Samii
Published: (2022-10-01)

Outcomes for unselected, newly diagnosed multiple myeloma patients
by: Jonathan T. Moore, et al.
Published: (2025-06-01)

Can you diagnose immune thrombocytopenia in myeloma? A case of thrombocytopenia in a patient with multiple myeloma
by: Cláudia Diogo, et al.
Published: (2024-11-01)

Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma
by: Grace M. Ferri, et al.
Published: (2025-01-01)

Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study
by: Dipal Mehta, et al.
Published: (2025-06-01)

Laboratory Mix Design of Asphalt Mixture Containing Reclaimed Material
by: Davide Lo Presti, et al.
Published: (2014-01-01)

The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients
by: Linlin Huang, et al.
Published: (2024-12-01)

EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS
by: A. S. Luchinin, et al.
Published: (2017-10-01)

How to Diagnose, Treat, and Monitor Treatment Response in Patients with Multiple Myeloma
by: Wulyo Rajabto, et al.
Published: (2022-09-01)

Clinical pathway for diagnosis and treatment of new diagnosed multiple myeloma in Guangxi
by: The Control Center of Medical Quality of Guangxi Hematology, et al.
Published: (2025-04-01)

The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients
by: Shohei Mizuno, et al.
Published: (2025-07-01)

Study of the Correlations among Some Parameters of the Oxidative Status, Gelatinases, and Their Inhibitors in a Group of Subjects with Metabolic Syndrome
by: E. Hopps, et al.
Published: (2014-01-01)

Prognostic value of peripheral eosinophil counts in patients with newly diagnosed multiple myeloma
by: Xu Chen, et al.
Published: (2025-05-01)

Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01)

Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma
by: Roberto Ria, et al.
Published: (2012-01-01)

Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients
by: Wen‐Ying Lin, et al.
Published: (2023-02-01)

IMPeTUs parameters correlate with clinical features in newly diagnosed multiple myeloma
by: Shuaishuai Xu, et al.
Published: (2024-12-01)

Organisation of the Work of Bioanalytical Laboratories according to the Principles of Good Clinical Laboratory Practice (Review)
by: I. S. Giba
Published: (2024-11-01)

Current Insights into Laboratory Markers for Diagnosing Metabolic Syndrome
by: Ayrapetyan, S.A., et al.
Published: (2025-04-01)

Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
by: Luciano J. Costa, et al.
Published: (2025-02-01)

MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
by: Francesca Fazio, et al.
Published: (2023-08-01)

Use of Minimal Residual Disease Status to Reduce Uncertainty in Estimating Long-term Survival Outcomes for Newly Diagnosed Multiple Myeloma Patients
by: Naomi van Hest, et al.
Published: (2023-01-01)

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?
by: Cristina Madaudo, et al.
Published: (2025-04-01)

Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
by: Graham H Jackson, et al.
Published: (2021-01-01)

Mothers balancing work and family: the associations with emotional well-being, sleep–wake problems and the role of basic needs
by: Rosalia Olivieri, et al.
Published: (2024-12-01)

Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma
by: Matthew J. Pianko, et al.
Published: (2025-12-01)

A new prognostic scoring system for newly diagnosed multiple myeloma in the era of new drugs
by: Ye Li, et al.
Published: (2024-10-01)

Selinexor combined with bortezomib, lenalidomide, and dexamethasone for the treatment of newly diagnosed multiple myeloma with extramedullary disease
by: Junjing Yin, et al.
Published: (2024-11-01)

The Rapidly Evolving Treatment Landscape in Newly Diagnosed Multiple Myeloma: Current Status and Future Directions
by: Yuxin Liu, et al.
Published: (2024-10-01)

Prognostic value of the expression of CD27 and CD117 in newly diagnosed multiple myeloma patients
by: Xu Si, et al.
Published: (2025-05-01)

EXPERIENCE IN DIAGNOSING RARE DIGESTIVE SYSTEM NEOPLASMS IN LABORATORY MICE
by: V. N. Manskikh, et al.
Published: (2016-02-01)

EXPERIENCE IN DIAGNOSING RARE BLOOD SYSTEM TUMORS IN LABORATORY MICE
by: V. N. Manskikh, et al.
Published: (2016-02-01)

METHOD AND ALGORITHMS OF CALCULATION OF PARAMETERS OF RELIABILITY IN ACCORDANCE WITH MULTIVARIATE DATA
by: E. M. Farhadzadeh, et al.
Published: (2017-01-01)

Calculation of the Friction Coefficients of Flax Stems according to their Roughness Characteristics
by: V. G. Chernikov, et al.
Published: (2019-02-01)

Construction and validation of an 18F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients
by: Xiaoqing Dong, et al.
Published: (2024-12-01)

Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK’s Haematological Malignancy Research Network
by: Alexandra Smith, et al.
Published: (2025-03-01)

Rational approaches to diagnosing gout (according to the European Antirheumatic League Guidelines)
by: V G Barskova, et al.
Published: (2007-09-01)